INAB IN8bio, Inc.
Healthcare$1.69+1.20%ClosedMarket Cap: $7.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.32
P/S
0.00
EV/EBITDA
0.70
DCF Value
$5.49
FCF Yield
-187.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-96.4%
ROA
-72.3%
ROIC
-76.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-5.3M | $-5.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.9M | $-4.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-19.9M | $-19.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.9M | $-3.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.1M | $-5.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.5M | $-5.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.2M | $-6.2M | $— | — |
| FY null | $0.00 | NaN% | $-30.4M | $-30.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.1M | $-7.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.6M | $-8.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.6M | $-8.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-7.9M | $-7.6M | $-0.21 | — |